Skip to main content

Table 1 The basic characteristics and comparison of drug resistance in seven group strains

From: A preliminary exploration on the mechanism of the carbapenem-resistance transformation of Serratia marcescens in vivo

Group

Age/sex

Strain NO.

Source

Ward

MICMEM

(µg/ml)

Date

blaKPC

Other resistant genes*

CMY

62/F

62

sputum

Neurosurgery

0.0625

5/25/2017

-

blaCTX−M−14, blaSRT−1, qnrS1, aac(6’)-Ic

63

sputum

4

5/31/2017

+

LAC

66/M

83

sputum

Neurosurgery

0.0625

8/22/2019

-

blaSRT−1,qnrS1, aac(3)-IId, aac(6’)-Ic, blaLAP−2

86

sputum

2

8/30/2019

+

YQS

50/M

88

sputum

ICU

0.0625

9/11/2019

-

blaCTX−M−14, blaLAP−2, blaSRT−1, qnrS1, aac(6’)-Ic, aac(3)-Iid

89

sputum

64

9/12/2019

+

ZFB

60/F

42

sputum

Neurosurgery

0.5

6/21/2017

-

blaCTX−M−14, qnrS1, blaLAP−2, blaSRT−1, aac(6’)-Ic

125

sputum

32

7/31/2017

+

FZX

62/M

24

sputum

ICU

1

7/8/2014

+

blaSRT−1, blaSRT−2, aac(6’)-Ic

26

sputum

32

7/15/2014

+

YZY

89/M

82

sputum

Gerontology

8

8/14/2019

+

blaSRT−1, blaSRT−2, qnrS1, aac(6’)-Ic

152

sputum

64

10/17/2019

+

LCD

58/M

31

blood

Infection

0.5

1/31/2015

-

blaCTX−M−14, blaLAP−2, blaSRT−1, blaOXA−1, qnrS1, ARR-3, mph(A), aac(6’)-Ib-cr, aac(6’)-Ic, aac(3)-Iid, catB3,qacE, aac(6’)-Ib-cr, sul1

34

sputum

8

3/1/2015

-

  1. *: including β-lactam, quinolone and aminoglycoside resistance genes